VMVictor Menezes

Victor Menezes

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Victor Menezes has a total of 18 co-authors. Here are the top co-authors by number of shared publications:

  • Anthony J. Kim

    Department of Neurosurgery, University of Maryland School of Medicine, Baltimore, MD 21202, United States; University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD 21201, United States; Fischell Department of Bioengineering, A. James Clark School of Engineering, University of Maryland, College Park, MD 20742, United States.; Department of Pharmacology, University of Maryland School of Medicine, Baltimore, MD 21201, United States.

    2 shared publications
  • Anton Bryksin

    Institute of Bioengineering and Bioscience Georgia Institute of Technology Atlanta Georgia United States

    2 shared publications
  • Chetan Bettegowda

    Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, MD

    2 shared publications
  • Chulyong Kim

    Woodruff School of Mechanical Engineering, Georgia Institute of Technology, Atlanta, Georgia, USA (C.K., C.A.)

    2 shared publications
  • Costas Arvanitis

    Woodruff School of Mechanical Engineering, Georgia Institute of Technology, Atlanta, USA

    2 shared publications
  • Cynthia M. Baseman

    School of Interactive Computing, Georgia Institute of Technology, Atlanta, Georgia, USA

    2 shared publications

Latest Publications

  • Open Access

    Data‐Driven Feedback Identifies Focused Ultrasound Exposure Regimens for Improved Nanotheranostic Targeting of the Brain

    by Hohyun Lee, Victor Menezes, Shiqin Zeng, Chulyong Kim, Cynthia M. Baseman, Jae Hyun Kim, Samhita Padmanabhan, Pranav Premdas, Naima Djeddar, Anton Bryksin, et al.

    The blood‐brain barrier (BBB) renders the delivery of nanomedicine in the brain ineffective and the detection of circulating disease‐related DNA from the brain unreliable. Here, we demonstrate that microbubble‐enhanced focused ultrasound (MB‐FUS) mediated BBB opening, supported by large‐data models predict sonication regimens for safe and effective BBB opening. Importantly, a closed‐loop MB‐FUS controller augmented by machine learning (ML‐CL) expands the treatment window, as compared to conventional controllers, by persistently and proactively maximizing the BBB permeability while preventing tissue damage. By successfully scaling up from mice to rats and from healthy to diseased brains (glioma), ML‐CL rendered the BBB permeable to large nanoparticles and markedly improved the release and detection of reporter gene DNA from tumors in blood. Together, our findings reveal the potential of data‐driven feedback to support the development of next‐generation AI‐powered ultrasound systems for safe, robust, and efficient nanotheranostic targeting and treatment of brain diseases.


  • Open Access

    Data-driven feedback augments ultrasound nanotheranostics in brain tumors

    by Hohyun Lee, Victor Menezes, Shiqin Zeng, Chulyong Kim, Cynthia M. Baseman, Jae Hyun Kim, Samhita Padmanabhan, Pranav Premdas, Naima Djeddar, Anton Bryksin, et al.

    The blood-brain barrier (BBB) renders the delivery of nanomedicine in the brain ineffective and the detection of circulating disease-related DNA from the brain unreliable. Here, we show that the acoustic emission content of focused ultrasound-controlled microbubble dynamics (MB-FUS) incorporates precursor signals that allow large-data models to predict sonication regimens for safe and effective BBB opening. Crucially, closed-loop MB-FUS controller augmented by machine learning (ML-CL) expands the treatment window (4-fold), as compared to conventional controllers, by persistently and proactively maximizing the BBB permeability while preventing tissue damage. By successfully scaling up from mice to rats and from healthy to diseased brains (glioma), ML-CL rendered the BBB permeable to large nanoparticles and markedly improved the release and detection of tumor DNA in plasma. Together, our findings reveal the potential of data-driven feedback to support the development of next-generation AI-powered ultrasound systems for safe, robust, and efficient nanotheranostic targeting of brain diseases.